Acadian Asset Management
ALIM

Acadian Asset Management’s Alimera Sciences ALIM Stock Holding History

Acadian Asset Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,263
Closed -$22K – 1834
2023
Q4 		$22K Sell
5,263
-2,410
-31% -$8.14K ﹤0.01% 1582
2023
Q3 		$23K Sell
7,673
-11,869
-61% -$39.2K ﹤0.01% 1530
2023
Q2 		$56K Hold
19,542
– – ﹤0.01% 1512
2023
Q1 		$40K Hold
19,542
– – ﹤0.01% 1551
2022
Q4 		$52K Hold
19,542
– – ﹤0.01% 1578
2022
Q3 		$98K Hold
19,542
– – ﹤0.01% 1369
2022
Q2 		$107K Hold
19,542
– – ﹤0.01% 1343
2022
Q1 		$108K Hold
19,542
– – ﹤0.01% 1345
2021
Q4 		$99K Hold
19,542
– – ﹤0.01% 1379
2021
Q3 		$81K Buy
19,542
+4,907
+34% +$34.2K ﹤0.01% 1489
2021
Q2 		$133K Sell
14,635
-2,315
-14% -$22.7K ﹤0.01% 1557
2021
Q1 		$163K Buy
16,950
+7,878
+87% +$64.5K ﹤0.01% 1556
2020
Q4 		$38K Buy
9,072
+4,293
+90% +$19.2K ﹤0.01% 2010
2020
Q3 		$23K Buy
+4,779
New +$28.1K ﹤0.01% 2062

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management's ALIM Position: Q1 2024 in Review

Acadian Asset Management sold out of Alimera Sciences (ALIM) in Q1 2024, closing a stake of 5,263 shares — an estimated $22K sold.

Acadian Asset Management first reported a position in ALIM in Q3 2020 and held it in 14 quarters. The position peaked at $163K in Q1 2021. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2024.

  • Acadian Asset Management reported no remaining Alimera Sciences position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 5,263 Alimera Sciences shares in Q1 2024, an estimated $22K.
  • Acadian Asset Management first reported a position in Alimera Sciences in Q3 2020 and held it in 14 quarters.
  • Acadian Asset Management's Alimera Sciences position peaked at $163K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.